Handelsavisen
prelaunch
Companies Basic Materials NOCI.NS
NO
NOCI.NS NSE (India) Commodity Chemicals

Noci.Ns

$164,48
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
1,12 %
Op margin
6,1 %
ROE
5,8 %
Net margin
7,4 %
Debt / equity
0,01
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

NOCI.NS is a chemical manufacturing company that produces commodity chemicals and generates revenue primarily through the sale of chemical products to industrial and consumer markets.

Business. NOCI.NS is a chemical manufacturing company that produces commodity chemicals and generates revenue primarily through the sale of chemical products to industrial and consumer markets.

Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustryCommodity Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
BUY5 analysts
2 buy3 hold0 sell
Avg 12m price target190,60

Analyst recommendations

5 analysts · consensus Buy
Buy2
Hold3
Sell0
12-month price target
190,60
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
5 analysts · indicative
Ownership
not yet wired
Profitability
5,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning NOCI.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to NOCI.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    NOCI.NS is a chemical manufacturing company that produces commodity chemicals and generates revenue primarily through the sale of chemical products to industrial and consumer markets.

    Classification92 %
    SectorBasic Materials
    Business sectorChemicals
    IndustryCommodity Chemicals
    ActivityChemicals
    AI synthesis
    GENERATED

    NOCI.NS has a strong capital structure with a low debt-to-equity ratio of 0.01, indicating minimal reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 5.82, suggesting it has sufficient short-term assets to cover its liabilities. However, the company has negative net cash after subtracting total debt, which could pose a liquidity risk in the short term.

    In terms of profitability, NOCI.NS has a return on equity (ROE) of 5.84% and a return on assets (ROA) of 5.00%. These figures are below the industry median for ROE and ROA, indicating that the company is underperforming relative to its peers in terms of generating returns on equity and assets. The company's operating income of INR 855.7 million and net income of INR 102.86 million reflect a relatively modest profit margin compared to industry benchmarks.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification reported. This lack of diversification could expose the company to higher operational and market risks if demand in its primary market segment or region declines. The absence of detailed segment and geographic breakdowns in the available data limits the ability to assess the extent of revenue concentration.

    NOCI.NS is projected to experience moderate growth in the current fiscal year, with revenue expected to increase by a small percentage. However, the outlook for the next fiscal year is less certain, with no significant growth anticipated. The company's capital expenditure of INR 1.2255 billion indicates a focus on maintaining and expanding its production capabilities, but the free cash flow of INR -163.5 million suggests that the company is currently investing more in operations than it is generating in cash.

    The company's risk profile is characterized by a low dilution potential and a medium liquidity risk. The absence of significant dilution sources in the available data suggests that the company is not currently issuing new shares at a rate that would significantly dilute existing shareholders. However, the negative net cash position and the company's reliance on operating cash flow to fund operations could increase liquidity risk in the near term.

    Recent events, including analyst estimates and price targets, indicate a mixed outlook for NOCI.NS. The mean price target of INR 190.60 and the median price target of INR 190.00 suggest that analysts have a cautiously optimistic view of the company's stock. However, the range of price targets, from INR 163.00 to INR 217.00, reflects a degree of uncertainty among analysts regarding the company's future performance.

    Key takeaways
    • NOCI.NS has a low debt-to-equity ratio, indicating a conservative capital structure.
    • The company's return on equity and return on assets are below industry medians, suggesting underperformance in profitability.
    • Revenue concentration in a single segment and lack of geographic diversification increase operational and market risks.
    • The company is projected to experience moderate growth in the current fiscal year, with limited growth expected in the next fiscal year.
    • Analysts have a cautiously optimistic view of NOCI.NS, with a mean price target of INR 190.60.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $164,48
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $17.62B
    Net cash
    -$103.0M
    Current ratio
    5.8
    Debt / equity
    0.0
    ROA
    5.0%
    ROE
    5.8%
    Cash conversion
    25.0%
    CapEx / revenue
    -8.8%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    3,92
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    5
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-04 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate3,92
    Revenueno estimateno estimate13,2B INR
    Operating incomeno estimateno estimate732,3M INR
    Full-year consensus mean (period as reported by source) · consensus in INR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution5 analysts
    Strong buy1
    Buy1
    Hold3
    Sell0
    Strong sell0
    12-month price target$190,60 · Median $190,00
    Low $163,00High $217,00
    Operating income · consensus732,3M INR
    EPS surprise
    +56,7 %
    reported vs consensus · beat
    Revenue surprise
    +5,7 %
    reported vs consensus · beat

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$163,00
    Mean$190,60
    Median$190,00
    High$217,00
    Spot$164,48
    +15.9 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin6,1 %Above median
    Net Margin7,4 %Above median
    ROE5,8 %Above median
    Capex / Rev-8,8 %Below median
    D/E0,01Above P75
    Cash Conv0,25Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • NOCI.NS Market data — financials · 2026-05-28
    • Nocil Ltd Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Leadership

    • Hrishikesh Arvind MafatlalExecutive Chairman of the Board

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    NOCI.NSCanonical
    NSE (India) · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage